Scarica l'app Stockscreener
36.50
1.96%
0.70
Pre-mercato:
36.67
0.17
+0.47%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$35.80
Aprire:
$35.77
Volume 24 ore:
4.20M
Relative Volume:
1.17
Capitalizzazione di mercato:
$15.78B
Reddito:
$2.31B
Utile/perdita netta:
$1.66B
Rapporto P/E:
15.87
EPS:
2.3
Flusso di cassa netto:
$827.02M
1 W Prestazione:
+0.91%
1M Prestazione:
-2.87%
6M Prestazione:
+10.57%
1 anno Prestazione:
+29.85%
Intervallo 1D:
$35.77
$36.57
Intervallo di 1 settimana:
$34.08
$37.28
Portata 52W:
$24.05
$38.00
Royalty Pharma Plc Stock (RPRX) Company Profile
Nome
Royalty Pharma Plc
Settore
Industria
Telefono
(212) 883-0200
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Confronta RPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
36.50 | 15.48B | 2.31B | 1.66B | 827.02M | 2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.48 | 101.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
482.13 | 59.64B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.53 | 59.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
767.00 | 47.00B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
351.13 | 38.12B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-16 | Iniziato | Morgan Stanley | Overweight |
| 2024-06-03 | Downgrade | UBS | Buy → Neutral |
| 2022-06-14 | Ripresa | UBS | Buy |
| 2022-05-13 | Iniziato | Scotiabank | Sector Outperform |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-30 | Iniziato | Tigress Financial | Buy |
| 2020-11-09 | Aggiornamento | UBS | Neutral → Buy |
| 2020-07-14 | Iniziato | Evercore ISI | In-line |
| 2020-07-13 | Iniziato | BofA Securities | Buy |
| 2020-07-13 | Iniziato | Citigroup | Neutral |
| 2020-07-13 | Iniziato | Cowen | Outperform |
| 2020-07-13 | Iniziato | Goldman | Neutral |
| 2020-07-13 | Iniziato | JP Morgan | Neutral |
| 2020-07-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Iniziato | SunTrust | Buy |
| 2020-07-13 | Iniziato | UBS | Neutral |
Mostra tutto
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
87% of Pharma Leaders Embrace Royalty Funding: Royalty Pharma's Groundbreaking Industry Study Reveals Shift - Stock Titan
Nomura Holdings Inc. Makes New Investment in Royalty Pharma PLC $RPRX - MarketBeat
Eventide Asset Management LLC Acquires 56,419 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Cutter Capital Management LP Trims Stake in Royalty Pharma PLC $RPRX - MarketBeat
Panagora Asset Management Inc. Cuts Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma’s $2 Billion Debt Raise Could Be a Game Changer for RPRX - simplywall.st
Baird Financial Group Inc. Cuts Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Amundi Sells 1,316,620 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma plc likely to announce a buyback2025 Price Targets & AI Enhanced Trade Execution Alerts - 뉴스영
Punch & Associates Investment Management Inc. Purchases 101,390 Shares of Royalty Pharma PLC $RPRX - MarketBeat
AQR Capital Management LLC Acquires 704,414 Shares of Royalty Pharma PLC $RPRX - MarketBeat
What is the long term forecast for Royalty Pharma plc stock2025 Support & Resistance & AI Driven Price Forecasts - beatles.ru
Is Royalty Pharma plc stock technically oversoldJuly 2025 Fed Impact & Free High Accuracy Swing Entry Alerts - beatles.ru
Royalty Pharma PLC $RPRX Holdings Cut by Adage Capital Partners GP L.L.C. - MarketBeat
Evergreen Capital Management LLC Has $453,000 Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Will Royalty Pharma plc benefit from AI trends2025 Price Momentum & Growth Focused Stock Pick Reports - 강소기업뉴스
Walleye Capital LLC Lowers Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Sold by BNP Paribas Financial Markets - MarketBeat
Royalty Pharma prices $2B senior unsecured notes - MSN
Canada Pension Plan Investment Board Sells 151,617 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Can technical indicators confirm Royalty Pharma plc’s reversalTrade Risk Report & Free High Return Stock Watch Alerts - Newser
How to interpret RSI for Royalty Pharma plc stockMarket Movers & Risk Controlled Stock Alerts - Newser
Ieq Capital LLC Boosts Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
What MACD and RSI say about Royalty Pharma plcWeekly Market Outlook & Precise Buy Zone Tips - Newser
Will breakout in Royalty Pharma plc lead to full recoveryTrade Entry Summary & Community Verified Watchlist Alerts - Newser
Royalty Pharma PLC $RPRX Shares Bought by American Century Companies Inc. - MarketBeat
Is Royalty Pharma plc gaining market shareEarnings Overview Report & Growth Focused Stock Reports - خودرو بانک
strategies to average down on royalty pharma plcJuly 2025 Gainers & Free Real-Time Volume Trigger Notifications - Newser
Applying sector rotation models to Royalty Pharma plc2025 Price Targets & Safe Entry Zone Tips - Newser
Will Royalty Pharma plc continue its uptrend2025 Volatility Report & Fast Exit and Entry Trade Guides - Newser
Royalty Pharma PLC $RPRX Shares Sold by AlTi Global Inc. - MarketBeat
Applying Wyckoff theory to Royalty Pharma plc stockJuly 2025 Market Mood & Long-Term Safe Investment Ideas - Newser
Royalty Pharma PLC $RPRX Shares Purchased by OMERS ADMINISTRATION Corp - MarketBeat
GMT Capital Corp Has $74.01 Million Position in Royalty Pharma PLC $RPRX - MarketBeat
Strategies to average down on Royalty Pharma plcGap Up & Breakout Confirmation Trade Signals - Newser
Intraday pattern recognizer results for Royalty Pharma plcPortfolio Performance Report & AI Based Trade Execution Alerts - Newser
Wall Street Zen Upgrades Royalty Pharma (NASDAQ:RPRX) to Buy - MarketBeat
Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - The Manila Times
Leading Biopharma Royalty Investor Royalty Pharma to Join Morgan Stanley Healthcare Conference Sept 9 - Stock Titan
Magnetar Financial LLC Buys Shares of 161,496 Royalty Pharma PLC $RPRX - MarketBeat
What does recent volatility data suggest for Royalty Pharma plc2025 Geopolitical Influence & Community Verified Trade Signals - Newser
Royalty Pharma plc stock outlook for YEARDollar Strength & Low Drawdown Momentum Trade Ideas - Newser
Royalty Pharma plc stock prediction for this weekJuly 2025 Closing Moves & Free Safe Entry Trade Signal Reports - Newser
Is Royalty Pharma plc a candidate for recovery playJuly 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
Short interest data insights for Royalty Pharma plcM&A Rumor & Low Risk Entry Point Tips - Newser
Royalty Pharma plc stock volume spike explainedQuarterly Profit Review & Verified Momentum Watchlists - Newser
Royalty Pharma Plc Azioni (RPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):